Levulan Kerastick Interactions
There are 126 drugs known to interact with Levulan Kerastick (aminolevulinic acid topical), along with 2 disease interactions. Of the total drug interactions, 1 is major, and 125 are moderate.
- View all 126 medications that may interact with Levulan Kerastick
- View Levulan Kerastick disease interactions (2)
Most frequently checked interactions
View interaction reports for Levulan Kerastick (aminolevulinic acid topical) and the medicines listed below.
- acetaminophen
- amoxicillin / clavulanate
- aspirin
- cephalexin
- cholecalciferol
- clobetasol topical
- Cymbalta (duloxetine)
- Dexilant (dexlansoprazole)
- doxycycline
- Eliquis (apixaban)
- famotidine
- finasteride
- fluticasone nasal
- furosemide
- gabapentin
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- hydrochlorothiazide
- ibuprofen
- Levemir (insulin detemir)
- Lovaza (omega-3 polyunsaturated fatty acids)
- Metoprolol Succinate ER (metoprolol)
- mycophenolate mofetil
- NeilMed Sinus Rinse Kit (sodium chloride nasal)
- nifedipine
- Novolog (insulin aspart)
- pantoprazole
- Pepto-Bismol (bismuth subsalicylate)
- prednisone
- rosuvastatin
- Vitamin D3 (cholecalciferol)
Levulan Kerastick disease interactions
There are 2 disease interactions with Levulan Kerastick (aminolevulinic acid topical) which include:
More about Levulan Kerastick (aminolevulinic acid topical)
- Levulan Kerastick consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical photochemotherapeutics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.